ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transdermal Drug Delivery Formulation Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-29L14450
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Transdermal Drug Delivery Formulation Market Research Report 2023
BUY CHAPTERS

Global Transdermal Drug Delivery Formulation Market Research Report 2025

Code: QYRE-Auto-29L14450
Report
May 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Mylan NV
Echo Therapeutics
Novartis
Hunan Jiudian
Tide Pharmaceutical
Luye Pharma
Kbd
Cosmed Pharmaceutical
GDB
Anssure Pharma
Novastage
LIANSN
GSK

Transdermal Drug Delivery Formulation Market

The global market for Transdermal Drug Delivery Formulation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Transdermal Drug Delivery Formulation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transdermal Drug Delivery Formulation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Transdermal Drug Delivery Formulation in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Transdermal Drug Delivery Formulation include Johnson & Johnson, Mylan, Echo Therapeutics, Novartis, GSK, Hunan Jiudian, Tide Pharmaceutical, Luye Pharma, GDB, Anssure Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery Formulation.
The Transdermal Drug Delivery Formulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Drug Delivery Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Drug Delivery Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Transdermal Drug Delivery Formulation Market Report

Report Metric Details
Report Name Transdermal Drug Delivery Formulation Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Mylan, Echo Therapeutics, Novartis, GSK, Hunan Jiudian, Tide Pharmaceutical, Luye Pharma, GDB, Anssure Pharma, Novastage, LIANSN, KBD, CosMED Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Transdermal Drug Delivery Formulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Transdermal Drug Delivery Formulation Market report?

Ans: The main players in the Transdermal Drug Delivery Formulation Market are Johnson & Johnson, Mylan, Echo Therapeutics, Novartis, GSK, Hunan Jiudian, Tide Pharmaceutical, Luye Pharma, GDB, Anssure Pharma, Novastage, LIANSN, KBD, CosMED Pharmaceutical

What are the Application segmentation covered in the Transdermal Drug Delivery Formulation Market report?

Ans: The Applications covered in the Transdermal Drug Delivery Formulation Market report are Hospital, Drug Store, Other

What are the Type segmentation covered in the Transdermal Drug Delivery Formulation Market report?

Ans: The Types covered in the Transdermal Drug Delivery Formulation Market report are Ointment, Glue, Cataplasm, Other

Recommended Reports

Drug Delivery Systems

Transdermal & Topicals

Microneedle & Advanced Tech

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Drug Delivery Formulation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ointment
1.2.3 Glue
1.2.4 Cataplasm
1.2.5 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery Formulation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery Formulation Market Perspective (2020-2031)
2.2 Global Transdermal Drug Delivery Formulation Growth Trends by Region
2.2.1 Global Transdermal Drug Delivery Formulation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transdermal Drug Delivery Formulation Historic Market Size by Region (2020-2025)
2.2.3 Transdermal Drug Delivery Formulation Forecasted Market Size by Region (2026-2031)
2.3 Transdermal Drug Delivery Formulation Market Dynamics
2.3.1 Transdermal Drug Delivery Formulation Industry Trends
2.3.2 Transdermal Drug Delivery Formulation Market Drivers
2.3.3 Transdermal Drug Delivery Formulation Market Challenges
2.3.4 Transdermal Drug Delivery Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery Formulation Players by Revenue
3.1.1 Global Top Transdermal Drug Delivery Formulation Players by Revenue (2020-2025)
3.1.2 Global Transdermal Drug Delivery Formulation Revenue Market Share by Players (2020-2025)
3.2 Global Transdermal Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transdermal Drug Delivery Formulation Revenue
3.4 Global Transdermal Drug Delivery Formulation Market Concentration Ratio
3.4.1 Global Transdermal Drug Delivery Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Formulation Revenue in 2024
3.5 Global Key Players of Transdermal Drug Delivery Formulation Head office and Area Served
3.6 Global Key Players of Transdermal Drug Delivery Formulation, Product and Application
3.7 Global Key Players of Transdermal Drug Delivery Formulation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery Formulation Breakdown Data by Type
4.1 Global Transdermal Drug Delivery Formulation Historic Market Size by Type (2020-2025)
4.2 Global Transdermal Drug Delivery Formulation Forecasted Market Size by Type (2026-2031)
5 Transdermal Drug Delivery Formulation Breakdown Data by Application
5.1 Global Transdermal Drug Delivery Formulation Historic Market Size by Application (2020-2025)
5.2 Global Transdermal Drug Delivery Formulation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transdermal Drug Delivery Formulation Market Size (2020-2031)
6.2 North America Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transdermal Drug Delivery Formulation Market Size by Country (2020-2025)
6.4 North America Transdermal Drug Delivery Formulation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery Formulation Market Size (2020-2031)
7.2 Europe Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transdermal Drug Delivery Formulation Market Size by Country (2020-2025)
7.4 Europe Transdermal Drug Delivery Formulation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery Formulation Market Size (2020-2031)
8.2 Asia-Pacific Transdermal Drug Delivery Formulation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transdermal Drug Delivery Formulation Market Size by Region (2020-2025)
8.4 Asia-Pacific Transdermal Drug Delivery Formulation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transdermal Drug Delivery Formulation Market Size (2020-2031)
9.2 Latin America Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transdermal Drug Delivery Formulation Market Size by Country (2020-2025)
9.4 Latin America Transdermal Drug Delivery Formulation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery Formulation Market Size (2020-2031)
10.2 Middle East & Africa Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transdermal Drug Delivery Formulation Market Size by Country (2020-2025)
10.4 Middle East & Africa Transdermal Drug Delivery Formulation Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Transdermal Drug Delivery Formulation Introduction
11.1.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Transdermal Drug Delivery Formulation Introduction
11.2.4 Mylan Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.2.5 Mylan Recent Development
11.3 Echo Therapeutics
11.3.1 Echo Therapeutics Company Details
11.3.2 Echo Therapeutics Business Overview
11.3.3 Echo Therapeutics Transdermal Drug Delivery Formulation Introduction
11.3.4 Echo Therapeutics Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.3.5 Echo Therapeutics Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Transdermal Drug Delivery Formulation Introduction
11.4.4 Novartis Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Transdermal Drug Delivery Formulation Introduction
11.5.4 GSK Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.5.5 GSK Recent Development
11.6 Hunan Jiudian
11.6.1 Hunan Jiudian Company Details
11.6.2 Hunan Jiudian Business Overview
11.6.3 Hunan Jiudian Transdermal Drug Delivery Formulation Introduction
11.6.4 Hunan Jiudian Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.6.5 Hunan Jiudian Recent Development
11.7 Tide Pharmaceutical
11.7.1 Tide Pharmaceutical Company Details
11.7.2 Tide Pharmaceutical Business Overview
11.7.3 Tide Pharmaceutical Transdermal Drug Delivery Formulation Introduction
11.7.4 Tide Pharmaceutical Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.7.5 Tide Pharmaceutical Recent Development
11.8 Luye Pharma
11.8.1 Luye Pharma Company Details
11.8.2 Luye Pharma Business Overview
11.8.3 Luye Pharma Transdermal Drug Delivery Formulation Introduction
11.8.4 Luye Pharma Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.8.5 Luye Pharma Recent Development
11.9 GDB
11.9.1 GDB Company Details
11.9.2 GDB Business Overview
11.9.3 GDB Transdermal Drug Delivery Formulation Introduction
11.9.4 GDB Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.9.5 GDB Recent Development
11.10 Anssure Pharma
11.10.1 Anssure Pharma Company Details
11.10.2 Anssure Pharma Business Overview
11.10.3 Anssure Pharma Transdermal Drug Delivery Formulation Introduction
11.10.4 Anssure Pharma Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.10.5 Anssure Pharma Recent Development
11.11 Novastage
11.11.1 Novastage Company Details
11.11.2 Novastage Business Overview
11.11.3 Novastage Transdermal Drug Delivery Formulation Introduction
11.11.4 Novastage Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.11.5 Novastage Recent Development
11.12 LIANSN
11.12.1 LIANSN Company Details
11.12.2 LIANSN Business Overview
11.12.3 LIANSN Transdermal Drug Delivery Formulation Introduction
11.12.4 LIANSN Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.12.5 LIANSN Recent Development
11.13 KBD
11.13.1 KBD Company Details
11.13.2 KBD Business Overview
11.13.3 KBD Transdermal Drug Delivery Formulation Introduction
11.13.4 KBD Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.13.5 KBD Recent Development
11.14 CosMED Pharmaceutical
11.14.1 CosMED Pharmaceutical Company Details
11.14.2 CosMED Pharmaceutical Business Overview
11.14.3 CosMED Pharmaceutical Transdermal Drug Delivery Formulation Introduction
11.14.4 CosMED Pharmaceutical Revenue in Transdermal Drug Delivery Formulation Business (2020-2025)
11.14.5 CosMED Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Mylan NV
Echo Therapeutics
Novartis
Hunan Jiudian
Tide Pharmaceutical
Luye Pharma
Kbd
Cosmed Pharmaceutical
GDB
Anssure Pharma
Novastage
LIANSN
GSK
List of Tables
 Table 1. Global Transdermal Drug Delivery Formulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Ointment
 Table 3. Key Players of Glue
 Table 4. Key Players of Cataplasm
 Table 5. Key Players of Other
 Table 6. Global Transdermal Drug Delivery Formulation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Transdermal Drug Delivery Formulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Transdermal Drug Delivery Formulation Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Transdermal Drug Delivery Formulation Market Share by Region (2020-2025)
 Table 10. Global Transdermal Drug Delivery Formulation Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Transdermal Drug Delivery Formulation Market Share by Region (2026-2031)
 Table 12. Transdermal Drug Delivery Formulation Market Trends
 Table 13. Transdermal Drug Delivery Formulation Market Drivers
 Table 14. Transdermal Drug Delivery Formulation Market Challenges
 Table 15. Transdermal Drug Delivery Formulation Market Restraints
 Table 16. Global Transdermal Drug Delivery Formulation Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Transdermal Drug Delivery Formulation Market Share by Players (2020-2025)
 Table 18. Global Top Transdermal Drug Delivery Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery Formulation as of 2024)
 Table 19. Ranking of Global Top Transdermal Drug Delivery Formulation Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Transdermal Drug Delivery Formulation Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Transdermal Drug Delivery Formulation, Headquarters and Area Served
 Table 22. Global Key Players of Transdermal Drug Delivery Formulation, Product and Application
 Table 23. Global Key Players of Transdermal Drug Delivery Formulation, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Transdermal Drug Delivery Formulation Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Transdermal Drug Delivery Formulation Revenue Market Share by Type (2020-2025)
 Table 27. Global Transdermal Drug Delivery Formulation Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Transdermal Drug Delivery Formulation Revenue Market Share by Type (2026-2031)
 Table 29. Global Transdermal Drug Delivery Formulation Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Transdermal Drug Delivery Formulation Revenue Market Share by Application (2020-2025)
 Table 31. Global Transdermal Drug Delivery Formulation Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Transdermal Drug Delivery Formulation Revenue Market Share by Application (2026-2031)
 Table 33. North America Transdermal Drug Delivery Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Transdermal Drug Delivery Formulation Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Transdermal Drug Delivery Formulation Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Transdermal Drug Delivery Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Transdermal Drug Delivery Formulation Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Transdermal Drug Delivery Formulation Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Transdermal Drug Delivery Formulation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Transdermal Drug Delivery Formulation Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Transdermal Drug Delivery Formulation Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Transdermal Drug Delivery Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Transdermal Drug Delivery Formulation Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Transdermal Drug Delivery Formulation Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Transdermal Drug Delivery Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Transdermal Drug Delivery Formulation Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Transdermal Drug Delivery Formulation Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Johnson & Johnson Company Details
 Table 49. Johnson & Johnson Business Overview
 Table 50. Johnson & Johnson Transdermal Drug Delivery Formulation Product
 Table 51. Johnson & Johnson Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 52. Johnson & Johnson Recent Development
 Table 53. Mylan Company Details
 Table 54. Mylan Business Overview
 Table 55. Mylan Transdermal Drug Delivery Formulation Product
 Table 56. Mylan Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 57. Mylan Recent Development
 Table 58. Echo Therapeutics Company Details
 Table 59. Echo Therapeutics Business Overview
 Table 60. Echo Therapeutics Transdermal Drug Delivery Formulation Product
 Table 61. Echo Therapeutics Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 62. Echo Therapeutics Recent Development
 Table 63. Novartis Company Details
 Table 64. Novartis Business Overview
 Table 65. Novartis Transdermal Drug Delivery Formulation Product
 Table 66. Novartis Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 67. Novartis Recent Development
 Table 68. GSK Company Details
 Table 69. GSK Business Overview
 Table 70. GSK Transdermal Drug Delivery Formulation Product
 Table 71. GSK Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 72. GSK Recent Development
 Table 73. Hunan Jiudian Company Details
 Table 74. Hunan Jiudian Business Overview
 Table 75. Hunan Jiudian Transdermal Drug Delivery Formulation Product
 Table 76. Hunan Jiudian Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 77. Hunan Jiudian Recent Development
 Table 78. Tide Pharmaceutical Company Details
 Table 79. Tide Pharmaceutical Business Overview
 Table 80. Tide Pharmaceutical Transdermal Drug Delivery Formulation Product
 Table 81. Tide Pharmaceutical Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 82. Tide Pharmaceutical Recent Development
 Table 83. Luye Pharma Company Details
 Table 84. Luye Pharma Business Overview
 Table 85. Luye Pharma Transdermal Drug Delivery Formulation Product
 Table 86. Luye Pharma Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 87. Luye Pharma Recent Development
 Table 88. GDB Company Details
 Table 89. GDB Business Overview
 Table 90. GDB Transdermal Drug Delivery Formulation Product
 Table 91. GDB Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 92. GDB Recent Development
 Table 93. Anssure Pharma Company Details
 Table 94. Anssure Pharma Business Overview
 Table 95. Anssure Pharma Transdermal Drug Delivery Formulation Product
 Table 96. Anssure Pharma Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 97. Anssure Pharma Recent Development
 Table 98. Novastage Company Details
 Table 99. Novastage Business Overview
 Table 100. Novastage Transdermal Drug Delivery Formulation Product
 Table 101. Novastage Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 102. Novastage Recent Development
 Table 103. LIANSN Company Details
 Table 104. LIANSN Business Overview
 Table 105. LIANSN Transdermal Drug Delivery Formulation Product
 Table 106. LIANSN Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 107. LIANSN Recent Development
 Table 108. KBD Company Details
 Table 109. KBD Business Overview
 Table 110. KBD Transdermal Drug Delivery Formulation Product
 Table 111. KBD Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 112. KBD Recent Development
 Table 113. CosMED Pharmaceutical Company Details
 Table 114. CosMED Pharmaceutical Business Overview
 Table 115. CosMED Pharmaceutical Transdermal Drug Delivery Formulation Product
 Table 116. CosMED Pharmaceutical Revenue in Transdermal Drug Delivery Formulation Business (2020-2025) & (US$ Million)
 Table 117. CosMED Pharmaceutical Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Transdermal Drug Delivery Formulation Picture
 Figure 2. Global Transdermal Drug Delivery Formulation Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Transdermal Drug Delivery Formulation Market Share by Type: 2024 VS 2031
 Figure 4. Ointment Features
 Figure 5. Glue Features
 Figure 6. Cataplasm Features
 Figure 7. Other Features
 Figure 8. Global Transdermal Drug Delivery Formulation Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Transdermal Drug Delivery Formulation Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Drug Store Case Studies
 Figure 12. Other Case Studies
 Figure 13. Transdermal Drug Delivery Formulation Report Years Considered
 Figure 14. Global Transdermal Drug Delivery Formulation Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Transdermal Drug Delivery Formulation Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Transdermal Drug Delivery Formulation Market Share by Region: 2024 VS 2031
 Figure 17. Global Transdermal Drug Delivery Formulation Market Share by Players in 2024
 Figure 18. Global Top Transdermal Drug Delivery Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery Formulation as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery Formulation Revenue in 2024
 Figure 20. North America Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Transdermal Drug Delivery Formulation Market Share by Country (2020-2031)
 Figure 22. United States Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Transdermal Drug Delivery Formulation Market Share by Country (2020-2031)
 Figure 26. Germany Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Transdermal Drug Delivery Formulation Market Share by Region (2020-2031)
 Figure 34. China Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Transdermal Drug Delivery Formulation Market Share by Country (2020-2031)
 Figure 42. Mexico Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Transdermal Drug Delivery Formulation Market Share by Country (2020-2031)
 Figure 46. Turkey Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Transdermal Drug Delivery Formulation Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 50. Mylan Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 51. Echo Therapeutics Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 52. Novartis Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 53. GSK Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 54. Hunan Jiudian Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 55. Tide Pharmaceutical Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 56. Luye Pharma Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 57. GDB Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 58. Anssure Pharma Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 59. Novastage Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 60. LIANSN Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 61. KBD Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 62. CosMED Pharmaceutical Revenue Growth Rate in Transdermal Drug Delivery Formulation Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Transdermal and Transmucosal Drug Delivery Market Research Report 2024
Transdermal Diffusion System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transdermal Skin Patch Market Research Report 2025
Global Transdermal Absorption Patch Market Research Report 2025
OTC Transdermal Analgesic Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transdermal Medical Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Active Transdermal Drug Delivery Device Market Research Report 2024
Transdermal Therapeutic Systems TTS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transdermal Skin Patches Market Research Report 2024
Global Transdermal Analgesics Market Research Report 2024
Global TDS Transdermal Delivery Systems Market Insights Forecast to 2030
Microneedle Transdermal Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transdermal Transmission Patches Market Research Report 2024
Global Microneedles for Trans Intradermal Drug Delivery Market Research Report 2025
Global Medical Transdermal Patch Market Research Report 2025
Global Passive Transdermal Drug Delivery Market Research Report 2024
Liposomal Formulation Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sustained and Controlled Release Formulations Market Research Report 2025
Injectable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sterile Formulation Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Automatic Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8S20198
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Optically Clear PCR Strip Tubes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1L20132
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Avena Sativa Kernel Meal Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28Q19902
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions